IRIS Archives

Information and Referral and Internet Sightings

IRIS@LISTSERV.ICORS.ORG
Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Condense Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Mime-Version:
1.0
Sender:
Information and Referral and Internet Sightings <[log in to unmask]>
Subject:
Generic Olanzapine
From:
Sylvia Caras <[log in to unmask]>
Date:
Wed, 26 Oct 2011 07:30:04 -0700
Message-ID:
<[log in to unmask]>
Content-Type:
text/plain; charset="us-ascii"; format=flowed
Reply-To:
[log in to unmask]
Parts/Attachments:
text/plain (8 lines) 
The FDA approved the first generic versions of Zyprexa (olanzapine 
tablets) and Zyprexa Zydus (olanzapine orally disintegrating tablets) 
to treat schizophrenia and bipolar disorder.



Powered by LSoft's LISTSERV(R) list management software

ATOM RSS1 RSS2